De Sanctis Vincenzo, Tosetto Ilaria, Iughetti Lorenzo, Antoniazzi Franco, Clementi Maurizio, Toffolutti Tiziana, Facchin Paola, Monti Elena, Pisanello Lorena, Tonini Giorgio, Greggio Nella A
Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital Ferrara - Italy.
Pediatr Endocrinol Rev. 2012 Aug;9(4):727-33.
The growth of the human body depends from a complex interaction between nutritional, environmental and hormonal factors and by a large number of different genes. One of these genes, short stature homeobox (SHOX), is believed to play a major role in growth. SHOX haploinsufficiency is associated with a wide spectrum of conditions, all characterized growth failure such as Leri-Weill dyschondrosteosis, Turner syndrome, short stature with subtle auxological and radiological findings and the so called "idiopathic short stature" (short stature with no specific findings other than growth failure). The document was prepared by a multidisciplinary team (paediatric endocrinologists, paediatrician, radiologist, geneticist and epidemiologist) to focus on the investigation of children with suspected SHOX- deficiency (SHOX-D) for an early identification and a correct diagnostic work - up of this genetic disorder. On the basis of a number of screening studies, SHOX-D appears to be a relatively frequent cause of short stature. The following recommendations were suggested by our multidisciplinary team: (i) a careful family history, measurements of body proportions and detection of any dysmorphic features are important for the suspect of a genetic disorder ,(ii)the presence of any combination of the following physical findings, such as reduced arm span/height ratio, increased sitting height/height ratio, above average BMI, Madelung deformity, cubitus valgus, short or bowed forearm, dislocation of the ulna at the elbow, or the appearance of muscular hypertrophy, should prompt the clinician to obtain a molecular analysis of the SHOX region, (iii) it is of practical importance to recognise early or mild signs of Madelung deformity on hand and wrist radiographs, (iv) growth hormone ,after stimulation test, is usually normal. However, treatment with rhGH may improve final adult height; the efficacy of treatment is similar to that observed in those treated for Turner syndrome.
人体的生长取决于营养、环境和激素因素之间的复杂相互作用以及大量不同的基因。这些基因之一,即矮小同源盒基因(SHOX),被认为在生长中起主要作用。SHOX单倍体不足与一系列病症相关,所有这些病症的特征都是生长发育迟缓,如勒里-韦伊软骨发育不全、特纳综合征、具有细微体格和放射学表现的身材矮小以及所谓的“特发性矮小”(除生长发育迟缓外无特定表现的身材矮小)。该文件由一个多学科团队(儿科内分泌学家、儿科医生、放射科医生、遗传学家和流行病学家)编写,重点是对疑似SHOX缺乏症(SHOX-D)儿童进行调查,以便早期识别和正确诊断这种遗传疾病。根据多项筛查研究,SHOX-D似乎是身材矮小的一个相对常见的原因。我们的多学科团队提出了以下建议:(i)仔细询问家族史、测量身体比例以及检测任何畸形特征对于怀疑患有遗传疾病很重要;(ii)存在以下任何身体表现的组合,如臂展/身高比值降低、坐高/身高比值增加、BMI高于平均水平、马德隆畸形、肘外翻、前臂短或弯曲、尺骨在肘部脱位或肌肉肥大的表现,应促使临床医生对SHOX区域进行分子分析;(iii)在手和腕部X光片上识别马德隆畸形的早期或轻微迹象具有实际重要性;(iv)生长激素在刺激试验后通常正常。然而,用重组人生长激素治疗可能会改善最终成人身高;治疗效果与特纳综合征患者的治疗效果相似。